Skip to main content
PMC home page
Scientific Reports logoLink to Scientific Reports
. 2022 May 12;12:7797. doi: 10.1038/s41598-022-11790-9

Novel pfk13 polymorphisms in Plasmodium falciparum population in Ghana

Sena Adzoa Matrevi 1, Kwesi Zandoh Tandoh 2, Selassie Bruku 1, Philip Opoku-Agyeman 1, Tryphena Adams 1, Nana Aba Ennuson 1, Bright Asare 1, Oheneba Charles Kofi Hagan 2, Benjamin Abuaku 1, Kwadwo Ansah Koram 1, Ann Fox 3, Neils Ben Quashie 1,4, Andrew G Letizia 3, Nancy Odurowah Duah-Quashie 1,✉
PMCID: PMC9098865  PMID: 35551239

Abstract

The molecular determinants of Plasmodium falciparum artemisinin resistance are the single nucleotide polymorphisms in the parasite’s kelch propeller domain, pfk13. Validated and candidate markers are under surveillance in malaria endemic countries using artemisinin-based combination therapy. However, pfk13 mutations which may confer parasite artemisinin resistance in Africa remains elusive. It has therefore become imperative to report all observed pfk13 gene polymorphisms in malaria therapeutic efficacy studies for functional characterization. We herein report all novel pfk13 mutations observed only in the Ghanaian parasite population. In all, 977 archived samples from children aged 12 years and below with uncomplicated malaria from 2007 to 2017 were used. PCR/Sanger sequencing analysis revealed 78% (763/977) of the samples analyzed were wild type (WT) for pfk13 gene. Of the 214 (22%) mutants, 78 were novel mutations observed only in Ghana. The novel SNPs include R404G, P413H, N458D/H/I, C473W/S, R529I, M579T/Y, C580R/V, D584L, N585H/I, Q661G/L. Some of the mutations were sites and ecological zones specific. There was low nucleotide diversity and purifying selection at the pfk13 locus in Ghanaian parasite population. With increasing drug pressure and its consequent parasite resistance, documenting these mutations as baseline data is crucial for future molecular surveillance of P. falciparum resistance to artemisinin in Ghana.

Subject terms: Computational biology and bioinformatics, Genetics, Molecular biology, Medical research

Introduction

Malaria remains a challenge in Africa, where about 94% of global malaria morbidity and mortality occur1. The most virulent malaria parasite, Plasmodium falciparum is resistant to most antimalarials. In order to slow the development of resistance in the parasite, the use of artemisinin-based combination therapy (ACTs) was introduced in malaria endemic countries by the World Health Organization (WHO)2. However, the report of decreased artemisinin (ART) efficacy in Southeast Asia (SEA)3,4 is a huge impediment to disease control efforts. The discovery of mutations in the P. falciparum kelch propeller domain on chromosome 13 (pfk13) as markers has helped tremendously in molecular surveillance in malaria endemic countries4. The pfk13 validated markers include F446I, N458Y, M476I, Y493H, R539T, I543T, P553L, R561H, P574L and C580Y1,5,6. Other markers yet to be validated are P441L, G449A, C469F/Y, A481V, R515K, P527H, N537I/D, G538V, V568G, R622I and A675V1. The list of validated pfk13 resistant SNPs is increasing and updates are done by the WHO over time.

In Africa, molecular surveillance studies have reported several SNPs, including M472I, Y558C, K563R, P570L, P615S in Niger7, R622I in Ethiopia8, C473F in Senegal9, F434S, F442F, I684N in Nigeria10 and M472I, A569T in the Democratic Republic of Congo11. These observed SNPs, although they have not yet been functionally characterized to determine their role in ART resistance. However, these have to be documented because of the possibility that they could be selected with increasing drug pressure and become the markers of ART resistance in Africa. This scenario is possible because of the reported local emergence of pfk13 mutations in the Amazonia12,13.

Pfk13 SNPs reported from other disease endemic countries including some of the validated SNPs and their variants which were observed in Ghanaian malaria parasites from the same samples have already been published14. In this report we document all the novel SNPs that have been observed only in the Ghanaian parasite population because these could be of interest in the future. These SNPs have not been reported from any country as revealed from searches in published articles from PUBMED up to the date of submitting this article.

Results

Twenty-two percent of the total number of samples (214/977) had pfk13 mutations, of which 78 were unique SNPs and 95% of those were non-synonymous. Mutations were observed in 63 codons and ranged from one SNP per codon to three SNPs per codon (N458D, N458I, N458H). Most of the novel SNPs were seen in only one sample (frequency of 0.47%). The coastal zone consisting of Accra and Cape-Coast (which are also urban areas) had more novel SNPs than the forest (having 6 sites—Begoro, Bekwai, Koforidua, Hohoe, Tarkwa, Sunyani). Of the sites in the forest zone, Koforidua had the most novel SNPs compared to other sites of the same zone. All the novel SNPs are shown in Table 1. Unique mutations were observed at the different sites and ecological zones. The ecological zone unique SNPs are, C580R and K669E/N for coastal, M579T/Y and D584L for forest and N554P and A569P for the savannah.

Table 1.

Novel non-synonymous SNPs at the sentinel sites. All novel mutations have been cited under the domains of the kelch propeller region showing the codons with the mutation, the base changes and the sentinel site where they were observed.

Domains Codons Reference amino acid Observed amino acid Mutation Specific base change Site
BTB/POZ 404 R G AGA → GGA A → G Wa
411 R K AGA → AAA G → A Hohoe
412 N I AAT → ATC AT → TC Navrongo
412 N S AAT → AGT A → G Begoro
413 P H CCG → CAC CG → AC Hohoe
422 L F TTC → CTC T → C Wa
431 E Q GAA → CAA G → C Hohoe
432 A T GCA → ACA G → A Hohoe
442 F L TTC → CTC T → C Hohoe
Blade 1 445 V L GTA → CTA G → C Begoro, Wa
455 E K GAA → AAA G → A Hohoe, Koforidua, Wa
456 Y N TAT → AAT T → A Accra
458 N D AAT → GAT A → G Koforidua
458 N I AAT → ATT A → T Koforidua
458 N H AAT → CAT A → C Koforidua
461 E G GAA → GGA A → G Accra
469 C R TGC → CGC T → C Cape Coast
470 W R TGG → CGG T → C Cape Coast
473 C W TGT → TGG T → G Cape Coast
473 C S TGT → TCT G → C Hohoe
Blade 2 485 S G AGT → GGT A → G Koforidua
488 L F TTG → TTC G → C Cape Coast, Hohoe
494 V I GTT → ATT G → A Hohoe
499 N T AAC → ACC A → C Hohoe
510 V G GTG → GGG T → G Navrongo
510 V L GTG → TTG G → T Wa
522 S R AGT → AGG T → G Cape Coast
Blade 3 523 N K AAT → AAA T → A Sunyani
529 R K AGA → AAA G → A Cape Coast
529 R I AGA → ATA G → T Koforidua
530 N I AAT → ATT A → T Sunyani
530 N S AAT → TCA AAT → TCA Koforidua
532 C S TGT → AGT T → A Begoro
536 S A TCA → GCA T → G Bekwai
547 D E GAT → GAA T → A Cape Coast
547 D N GAT → AAT G → A Hohoe
554 N P AAT → CCT AA → CC Accra
554 N T AAT → ACT A → C Hohoe
555 V A GTA → GCA T → C Sunyani
556 E D GAA → GAT A → T Sunyani
559 D Y GAT → TAT G → T Navrongo
565 W R TGG → CGC TG → CC Begoro
569 A P GCA → CCA G → C Wa
Blade 4 578 A P GCT → CCT G → C Wa
579 M T ATG → ACG T → C Koforidua
579 M Y ATG → TAT ATG → TAT Cape Coast
580 C V TGT → GTG TGT → GTG Cape Coast
580 C R TGT → CGT T → C Begoro
584 D L GAT → TTG GAT → TTG Koforidua
585 N H AAT → CAT A → C Hohoe
585 N I AAT → ATA AT → TA Koforidua
587 I T ATT → ACT T → C Cape Coast
587 I N ATT → AAT T → A Cape Coast, Koforidua
590 I T ATT → ACT T → C Navrongo
598 L I TTA → ATA T → A Bekwai
605 E D GAA → GAC A → C Cape Coast
615 P L CCA → CTA C → T Cape Coast
Blade 5 616 Y H TAT → CAT T → C Koforidua
619 L V TTA → GTA T → G Begoro
623 S N AGT → AAT G → A Cape Coast
628 F L TTT → CTT T → C Cape Coast
628 F L TTT → TTA T → A Hohoe, Koforidua
633 Q H CAA → CAT A → T Accra
640 I F ATT → TTT A → T Cape Coast
640 I S ATT → AGT T → G Begoro
643 E D GAA → GAC A → C Cape Coast
646 I K ATA → AAA T → A Cape Coast
648 D Y GAT → TAT G → T Sunyani
661 Q L CAA → CTA A → T Cape Coast, Koforidua
661 Q G CAA → GCA CA → GC Koforidua
664 N H AAT → CAT A → C Cape Coast
Blade 6 668 E D GAG → GAT G → T Cape Coast, Koforidua
669 K E AAA → GAA A → G Cape Coast, Koforidua
669 K N AAA → AAC A → C Koforidua
672 N I AAT → ATT A → T Cape Coast, Koforidua
690 G D GGC → GAC G → A Cape Coast, Koforidua
692 V L GTT → CTT G → C Cape Coast
696 C S TGT → AGT T → A Cape Coast
Open in a new tab

Distribution of mutations in the pfk13 propeller domain in the Ghanaian isolates

Novel SNPs which were unique to the various sites were observed at different domains of the propeller region. The SNPs exclusive to Hohoe were mostly located within the BTB/POZ domain to blade 3 and those of Koforidua were located within blades 3 to 6. SNPs observed in the samples from Cape Coast were located within blades 4, 5 and 6 and those for Accra were found in blades 1, 3 and 5. Of the 78 novel mutations detected, the highest number of mutations were recorded in blade 3 and the least number in blades 2 and 6 as shown in Table 1.

P. falciparum k13 gene showed low diversity and evidence of purifying selection in Ghanaian parasite population

To investigate the diversity at the pfk13 locus, we determined population genetics metrics of DNA polymorphism using the 792 sequences in total. Overall genetic diversity at the pfk13 locus was low (π = 0.00383) (Table 2) and indicates that the gene locus sequence among the 792 samples analyzed was largely similar. This similarity or low genetic diversity did not change when analyzed per location, year, or ecological zone (Table 2; Figs. 1, 2, 3). Additionally, polymorphism measured by the number of segregating sites was 1034. The investigation of the evidence of selection acting on the pfk13 locus using the site frequency spectrum metric, Tajima's D was done. Positive values of Tajima's D are suggestive of balancing selection and negative values of purifying or negative selection. The analysis shows that the pfk13 gene, for the period and locations analyzed, was under purifying selection. A total of 307 haplotypes were found in the gene locus with a haplotype diversity of 0.6887. The forest ecological zone contributed the highest number of haplotypes (h = 159) and the year 2016 reported the highest number of haplotypes (h = 186).

Table 2.

Summary of computational analysis of DNA polymorphisms found in pfk13 in Ghanaian isolates by location, year and ecological zones. The computational analysis of the sequences to reveal the nucleotide diversity of the mutations in the pfk13 gene in Ghanaian isolates for study sites, year and ecological zones.

π S Tajima's D T’s D p value No. of haplotypes/haplotype diversity (h/Hd)
A. Location
Accra 0.00395 136 − 2.70944  < 0.001 29 (0.926)
Begoro 0.00418 222 − 2.80559  < 0.001 30 (0.759)
Bekwai 0.00589 232 − 2.66217  < 0.001 28 (0.754)
CapeCoast 0.00315 247 − 2.87368  < 0.001 48 (0.722)
Hohoe 0.00154 138 − 2.89841  < 0.001 44 (0.686)
Koforidua 0.00096 102 − 2.70784  < 0.001 28 (0.472)
Navrongo 0.00299 276 − 2.91636  < 0.001 41 (0.607)
Sunyani 0.00415 164 − 2.64914  < 0.001 22 (0.614)
Tarkwa 0.01467 89 − 1.15583  > 0.10 6 (1.000)
Wa 0.00303 87 − 2.55226  < 0.001 24 (0.906)
Total 0.00383 1034 − 2.85874  < 0.001 307 (0.6887)
B. Year
2007 0.00919 305 − 2.78904  < 0.001 23 (0.829)
2010 0.00798 344 − 2.74562  < 0.001 32 (0.666)
2012 0.00255 132 − 2.80328  < 0.001 18 (0.468)
2014 0.00688 255 − 2.57399  < 0.001 51 (0.879)
2016 0.00289 767 − 2.9292  < 0.001 186 (0.7127)
2017 0.00097 102 − 2.92075  < 0.001 28 (0.474)
Total 0.00383 1034 − 2.85874  < 0.001 307 (0.6887)
C. Ecological zones
Coastal 0.00504 460 − 2.9099  < 0.001 82 (0.827)
Forest 0.00326 706 − 2.88742  < 0.001 159 (0.6300)
Savannah 0.00458 491 − 2.94234  < 0.001 71 (0.731)
Total 0.00383 1034 − 2.85874  < 0.001 307 (0.6887)
Open in a new tab

S—number of segregating sites in the gene; π—nucleotide diversity at the gene locus.

Figure 1.

Figure 1

Open in a new tab

Sliding window plot of Tajima’s D for the pfk13 gene showing distribution by location/site. The computational analysis of the sequences to reveal the nucleotide diversity of the mutations in the pfk13 gene in Ghanaian isolates by study sites. Nucleotide positions is from 1000 to 2181 bp. Window length is 100 bp and step size is 25 bp.

Figure 2.

Figure 2

Open in a new tab

Sliding window plot of Tajima’s D for the pfk13 gene showing temporal distribution. The computational analysis of the sequences to reveal the nucleotide diversity of the mutations in the pfk13 gene in Ghanaian isolates by year.Nucleotide positions is from 1000 to 2181 bp. Window length is 100 bp and step size is 25 bp.

Figure 3.

Figure 3

Open in a new tab

Sliding window plot of Tajima’s D for the pfk13 gene showing distribution by ecological zones. The computational analysis of the sequences to reveal the nucleotide diversity of the mutations in the pfk13 gene in Ghanaian isolates by ecological zones. Nucleotide positions is from 1000 to 2181 bp. Window length is 100 bp and step size is 25 bp.

Discussion

The need to report all observed SNPs in the pfk13 gene is important especially when the molecular markers for resistance in Africa are yet to be revealed. From this study, sequence analysis revealed a number of novel SNPs observed only in the Ghanaian parasite population over a decade. Although the mutations are many in different codons of the gene locus, the frequencies were low and the computational DNA analysis showed low nucleotide diversity in the population which is under purifying selection. Our previous paper has already reported mutations seen in Ghanaian isolates that have been observed elsewhere including variants of some of the validated and candidate markers of ART resistance14. Functional characterisation using CRISPR Genome Editing Technology followed by Ring Stage Survival Assay (RSA) of two clones with one novel mutation, C580R; C580R_1 and C580R_2 showed parasite survival rates of 18% and 14% respectively and that of the validated marker, C580Y, was 28% in the same experiment (OCK Hagan et al., data yet to be published). The findings of this experiment support the fact that all observed mutations in pfk13 could be potential markers of drug resistance and therefore must be documented.

The unique mutations observed in the parasite population of Ghana were not shared, even among sites of the same ecological zone and could be a reflection of minimum gene flow between the sites within each zone12. This observation corroborates the findings from data available on resistance to ART. The data do not show a cluster of mutations geographically and there is lack of sharing of common mutations among parasite populations thereby resulting in regional diversity15–17. The novel mutations are as a result of genetic recombination and localised evolution of the gene, which is a consequence of high transmission intensity. The differences in the transmission patterns18–20 could be a probable explanation to the observed genetic variability. Inadvertently, most of the SNPs were observed in one sample and only a few were seen in 2 or 3 samples. The fact that they were non-synonymous mutations could also be affecting the fitness cost of the parasites and may not necessarily be linked to drug resistance. In addition, it could be an evidence of the start of an independent emergence of pfk13 mutations in Ghana as observed in the parasite population of Guyana12,16.

The mutations in the Ghanaian isolates were distributed in all the domains, from the BTB/POZ to blade 6 with variations in sentinel sites located in the same ecological zone. Most mutations were in blade 3 followed by blades 4 and 5 but with low frequencies. The propeller domain is known to be conserved in P. falciparum, however, the mutations observed could be parasite adaptation due to selective pressures of antimalarial drugs use in Africa (fake drugs, noncompliance and presumptive treatment of malaria)13,21. The large pool of low frequency genetic mutations could help with the emergence of resistance faster than anticipated due to increasing drug pressure from ACT use22. Unlike the high frequency of non-synonymous mutations in parasites of the SEA region moving from intermediate to fixation levels, those of Africa occur at very low frequencies with high allelic variation23.

Nucleotide diversity (π) at the pfk13 locus can be considered an indirect measure of the potential for the selection of an ART tolerant variant. A high π at the pfk13 suggests sufficient diversity for a soft or hard selection sweep on the locus. In contrast, a low π suggests a reduced probability for a selection sweep on the pfk13 locus. The finding of low diversity at the pfk13 locus in this regard suggests that the risk of a tolerant pfk13 variant emerging between 2007 and 2017 was low. It is also evident that pfk13 is largely conserved in the P. falciparum population of Ghana. This lack of diversity at the pfk13 locus may be due to the fitness cost of any new variant.

Within the context of relatively high transmissions that correlate with higher sexual outcrossing in the mosquito vector and thus the breakdown by recombination of any nascent pfk13 variant/haplotype, our findings are expected. Other factors that might mitigate against high diversity in the pfk13 locus include the prevalence of human malaria immunity and within-host multiplicity of infection/competition. These factors may act to negatively select emerging ART tolerant variants segregating in our population as portrayed by the results. The finding of negative Tajima’s D may also suggest recent population expansion with multiple low-frequency variants. This presence of several variants at low frequencies contributes to the haplotype diversity observed in the analysis. Additionally, the findings of low nucleotide diversity and purifying selection at the pfk13 locus is congruent with the findings of a similar study that investigated the evolution and genetic diversity of the pfk13 gene24.

Conclusion

A change in genetic composition and the resultant change in amino acids affects protein function. The observation of numerous novel mutations which are non-synonymous with low frequencies is indicative of the development of a nascent resistance at the genotypic level yet to be revealed as phenotypic traits in Ghanaian parasites. The current reported efficacies of ACTs is above 95%25 which is quite high as compared to some countries in the region. The novel mutations would be monitored continuously and functional characterization would be performed on those with increasing frequencies over time to establish their role in parasite resistance to ACTs in Ghana.

Methods

Study sites and population

Archived samples from therapeutic efficacy studies (TES) conducted in sentinel sites in three different ecological zones of Ghana namely coastal, forest and savannah were used for the study. Perennial transmission of malaria occurs in the coastal and forest zones and seasonal malaria transmission occurs in the savannah zone. The sentinel sites are Accra, Begoro, Bekwai, Cape-Coast, Hohoe, Koforidua, Navrongo, Sunyani, Tarkwa, Yendi and Wa (Fig. 4). Accra and Cape-Coast lie in the coastal savannah zone; Navrongo, Yendi and Wa lie in the guinea savannah zone; Begoro, Bekwai, Koforidua, Sunyani, Hohoe and Tarkwa lie in the forest zone. The information on the study sites is well documented in Matrevi et al.14.

Figure 4.

Figure 4

Open in a new tab

A map of Ghana showing the study sites in the ecological zones. These sites are designated for antimalarial drug therapeutic efficacy studies in all regions of Ghana.

Samples and molecular analysis

Archived filter paper blood blots, prepared from children 12 years and below reporting at the clinic with uncomplicated malaria from 2007 to 2017 malaria transmission season were used. The parents/guardians of the children gave informed consent for their participation in the studies. The consent also covered the future use of the archived samples for further molecular analysis. DNA was extracted using a QIAamp DNA Mini Kit (QIAGEN, Germany) following the manufacturer’s protocol. Targeted portion of pfk13 gene was amplified using the nested PCR protocol by Talundzic et al.26 with minor modifications. Positively amplified samples were Sanger sequenced by Macrogen, Europe (Netherlands).

Sequence analysis

Obtained sequences from the pfk13 genes were submitted to the standard nucleotide basic local alignment search tool (BLAST) database search program of the National Center for Biotechnology Information (NCBI) website to determine the authenticity of the sequences. The sequences were then aligned using 3D7 wild type pfk13 sequence (PF3D7_1343700) for reference obtained from PlasmoDB (www.Plasmodb.org). Sequences were edited using BioEdit ClustalW Multiple Sequence Alignment Software. They were further analysed using CLC Main Workbench 20.04 software (Qiagen, Aarhus, Denmark) and Benchling.com (San Francisco, CA, USA). Other single nucleotide polymorphisms were searched for using PubMed tool for new SNPs published by other researchers.

Computational pipeline for population genetics analysis of pfk13 gene

Base-calling, alignment, and deconvolution of Sanger chromatogram trace files were done using the command-line version of the application Tracy27. The output binary variant call format (bcf) files for each sample were converted to human-readable variant call format (vcf) files using custom bash scripts. Low-quality variants (< 40) and indels were filtered out from the vcf file. After this, vcf files were merged and variants extracted and annotated into a text file using custom bash scripts, SnpEff (v4.1), and vcftools. Fasta files were generated using custom bash scripts and fed into DnaSP6.0 to determine the DNA polymorphisms metrics and Tajima's D28.

Ethics declarations

The study protocol was approved by the Institutional Review Boards of the Noguchi Memorial Institute for Medical Research (NMIMR) and Naval Medical Research Center in compliance with all applicable federal regulations governing the protection of human subjects of the US Government. The IRB protocol number is 032/05-06a amed. 2021.

Acknowledgements

The hard work of medical staff and field workers on the TES is highly appreciated. This work, which includes the collection of the samples used in this study, was funded by the Global Fund to fight Aids, Tuberculosis and Malaria (GFATM)/National Malaria Control Programme, Ghana and the Global Emerging Infections Surveillance and Response Section (GEIS), a division of the US Armed Forces Health Surveillance Center (AFHSC).

Author contributions

N.O.D.Q., N.B.Q., B.A., A.L., A.F. and K.A.K. conceived and designed the study. S.A.M., K.Z.T., S.B., P.O.A., T.A., N.A.E., B.As and O.C.K.H. did the laboratory analysis of samples to generate molecular data and sequence analysis. S.A.M. and N.O.D.Q. drafted the manuscript. All authors read, reviewed and approved the final manuscript.

Data availability

All data generated or analyzed during this study are included in this published article. Raw sequence data is available upon reasonable request from the corresponding author.

Competing interests

The authors declare no competing interests.

Footnotes

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  • 1.WHO . World Malaria Report 2020. Geneva: World Health Organization; 2020. [Google Scholar]
  • 2.WHO . Antimalarial Drug Combination Therapy Report of a WHO Technical Consultation. Geneva: World Health Organization; 2001. [Google Scholar]
  • 3.Ashley EA, et al. Spread of artemisinin resistance in Plasmodium falciparum malaria. N. Engl. J. Med. 2014;371:411–423. doi: 10.1056/NEJMoa1314981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Ariey F, et al. A molecular marker of artemisinin-resistant Plasmodium falciparum malaria. Nature. 2014;505:50–55. doi: 10.1038/nature12876. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.WHO . Artemisinin Resistance and Artemisinin-Based Combination Therapy Efficacy. Geneva: World Health Organization; 2018. [Google Scholar]
  • 6.Straimer J, et al. Drug resistance. K13-propeller mutations confer artemisinin resistance in Plasmodium falciparum clinical isolates. Science. 2015;347(6220):428–431. doi: 10.1126/science.1260867. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Laminou IM, et al. Detection of Plasmodium falciparum k13 propeller A569G mutation after artesunate-amodiaquine treatment failure in Niger. J. Adv. Biol. Biotechnol. 2018;18(2):1–8. doi: 10.9734/JABB/2018/42872. [DOI] [Google Scholar]
  • 8.Bayih AG, et al. A unique Plasmodium falciparum k13 gene mutation in Northwest Ethiopia. Am. J. Trop. Med. Hyg. 2016;94(1):132–135. doi: 10.4269/ajtmh.15-0477. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Talundzic E, et al. Molecular epidemiology of Plasmodium falciparum kelch13 mutations in Senegal determined by using targeted amplicon deep sequencing. Antimicrob. Agents. Chemother. 2017;61(3):e02116–e2216. doi: 10.1128/AAC.02116-16. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Abubakar UF, et al. Identification of mutations in antimalarial resistance gene kelch13 from Plasmodium falciparum isolates in Kano, Nigeria. Trop. Med. Infect. Dis. 2020;5(2):85. doi: 10.3390/tropicalmed5020085. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Yobi DM, et al. The lack of K13-propeller mutations associated with artemisinin resistance in Plasmodium falciparum in Democratic Republic of Congo (DRC) PLoS ONE. 2020;15(8):e0237791. doi: 10.1371/journal.pone.0237791. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Mathieu LC, et al. Local emergence in amazonia of Plasmodium falciparum K13 C580Y mutants associated with in vitro artemisinin resistance”. Elife. 2020;9:e51015. doi: 10.7554/eLife.51015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.MalariaGen Plasmodium falciparum Community Project Genomic epidemiology of artemisinin resistant malaria. Elife. 2016;5:e08714. doi: 10.7554/eLife.08714. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Matrevi SA, et al. Plasmodium falciparum kelch propeller polymorphisms in clinical isolates from Ghana from 2007 to 2016. Antimicrob. Agents. Chemother. 2019;63(11):e00802–e819. doi: 10.1128/AAC.00802-19. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Taylor SM, et al. Absence of putative artemisinin resistance mutations among Plasmodium falciparum in Sub-Saharan Africa: A molecular epidemiologic study. J. Infect. Dis. 2015;211:680–688. doi: 10.1093/infdis/jiu467. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Chenet SM, et al. Independent emergence of the Plasmodium falciparum kelch propeller domain mutant allele C580Y in Guyana. J. Infect. Dis. 2016;213(9):1472–1475. doi: 10.1093/infdis/jiv752. [DOI] [PubMed] [Google Scholar]
  • 17.Tilley L, Straimer J, Gnädig NF, Ralph SA, Fidock DA. Artemisinin action and resistance in Plasmodium falciparum. Trends Parasitol. 2016;32(9):682–696. doi: 10.1016/j.pt.2016.05.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Dery DB, et al. Patterns and seasonality of malaria transmission in the forest-savannah transitional zones of Ghana. Malar. J. 2010;9:314. doi: 10.1186/1475-2875-9-314. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Tchouassi DP, et al. Characterization of malaria transmission by vector populations for improved interventions during the dry season in the Kpone-on-Sea area of coastal Ghana. Parasit. Vectors. 2012;26(5):212. doi: 10.1186/1756-3305-5-212. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Kasasa S, et al. Spatio-temporal malaria transmission patterns in Navrongo demographic surveillance site, northern Ghana. Malar. J. 2013;12:63. doi: 10.1186/1475-2875-12-63. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Ocan M, et al. Prevalence of K13-propeller gene polymorphisms among Plasmodium falciparum parasites isolated from adult symptomatic patients in northern Uganda. BMC Infect. Dis. 2016;16(1):428. doi: 10.1186/s12879-016-1777-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Apinjoh TO, Ouattara A, Titanji VPK, Djimde A, Amambua-Ngwa A. Genetic diversity and drug resistance surveillance of Plasmodium falciparum for malaria elimination: Is there an ideal tool for resource-limited sub-Saharan Africa? Malar. J. 2019;18(1):217. doi: 10.1186/s12936-019-2844-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Menard D, et al. A worldwide map of Plasmodium falciparum K13-propeller polymorphisms. N. Engl. J. Med. 2016;374:2453–2464. doi: 10.1056/NEJMoa1513137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Pacheco MA, et al. Evolution and genetic diversity of the k13 gene associated with artemisinin delayed parasite clearance in Plasmodium falciparum. Antimicrob. Agents. Chemother. 2019 doi: 10.1128/aac.02550-18. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Abuaku B, et al. Therapeutic efficacy of artesunate-amodiaquine and artemether-lumefantrine combinations for uncomplicated malaria in 10 sentinel sites across Ghana: 2015–2017. Malar. J. 2019;18(1):206. doi: 10.1186/s12936-019-2848-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Talundzic E, et al. Selection and spread of artemisinin-resistant alleles in Thailand prior to the global artemisinin resistance containment campaign. PLoS Pathog. 2015;11(4):e1004789. doi: 10.1371/journal.ppat.1004789. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Rausch T, Fritz MH, Untergasser A, Benes V. Tracy: Basecalling, alignment, assembly and deconvolution of sanger chromatogram trace files. BMC Genomics. 2020;21(1):230. doi: 10.1186/s12864-020-6635-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Rozas J. DNA sequence polymorphism analysis using DnaSP. Methods Mol. Biol. 2009;537:337–350. doi: 10.1007/978-1-59745-251-9_17. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

All data generated or analyzed during this study are included in this published article. Raw sequence data is available upon reasonable request from the corresponding author.

Articles from Scientific Reports are provided here courtesy of Nature Publishing Group

RESOURCES